158 related articles for article (PubMed ID: 32515123)
1. OSW-1 inhibits tumor growth and metastasis by NFATc2 on triple-negative breast cancer.
Ding X; Li Y; Li J; Yin Y
Cancer Med; 2020 Aug; 9(15):5558-5569. PubMed ID: 32515123
[TBL] [Abstract][Full Text] [Related]
2. Effect of OSW-1 on microRNA expression profiles of hepatoma cells and functions of novel microRNAs.
Jin JC; Jin XL; Zhang X; Piao YS; Liu SP
Mol Med Rep; 2013 Jun; 7(6):1831-7. PubMed ID: 23588479
[TBL] [Abstract][Full Text] [Related]
3. Sterol-recognition ability and membrane-disrupting activity of Ornithogalum saponin OSW-1 and usual 3-O-glycosyl saponins.
Malabed R; Hanashima S; Murata M; Sakurai K
Biochim Biophys Acta Biomembr; 2017 Dec; 1859(12):2516-2525. PubMed ID: 28947142
[TBL] [Abstract][Full Text] [Related]
4. Cholestane glycosides from Ornithogalum saundersiae bulbs and the induction of apoptosis in HL-60 cells by OSW-1 through a mitochondrial-independent signaling pathway.
Iguchi T; Kuroda M; Naito R; Watanabe T; Matsuo Y; Yokosuka A; Mimaki Y
J Nat Med; 2019 Jan; 73(1):131-145. PubMed ID: 30327993
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of OSW saponin analogs with modified sugar residues and their antiproliferative activities.
Tang P; Mamdani F; Hu X; Liu JO; Yu B
Bioorg Med Chem Lett; 2007 Feb; 17(4):1003-7. PubMed ID: 17127060
[TBL] [Abstract][Full Text] [Related]
6. OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis.
Wu M; Huang Q; Liao M; Wu X; Xi H; Ma H; Li S; Zhang Y; Xia Y
Cell Oncol (Dordr); 2022 Dec; 45(6):1255-1275. PubMed ID: 36155886
[TBL] [Abstract][Full Text] [Related]
7. Effective cytotoxic activity of OSW-1 on colon cancer by inducing apoptosis in vitro and in vivo.
Zhang Y; Fang F; Fan K; Zhang Y; Zhang J; Guo H; Yu P; Ma J
Oncol Rep; 2017 Jun; 37(6):3509-3519. PubMed ID: 28440433
[TBL] [Abstract][Full Text] [Related]
8. OSW-1: a natural compound with potent anticancer activity and a novel mechanism of action.
Zhou Y; Garcia-Prieto C; Carney DA; Xu RH; Pelicano H; Kang Y; Yu W; Lou C; Kondo S; Liu J; Harris DM; Estrov Z; Keating MJ; Jin Z; Huang P
J Natl Cancer Inst; 2005 Dec; 97(23):1781-5. PubMed ID: 16333034
[TBL] [Abstract][Full Text] [Related]
9. 23-oxa-analogues of OSW-1: efficient synthesis and extremely potent antitumor activity.
Shi B; Wu H; Yu B; Wu J
Angew Chem Int Ed Engl; 2004 Aug; 43(33):4324-7. PubMed ID: 15368382
[No Abstract] [Full Text] [Related]
10. Synthesis of analogues of a potent antitumor saponin OSW-1.
Morzycki JW; Wojtkielewicz A; Wołczyński S
Bioorg Med Chem Lett; 2004 Jun; 14(12):3323-6. PubMed ID: 15149699
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of cholestane glycosides bearing OSW-1 disaccharide or its 1-->4-linked analogue and their antitumor activities.
Zheng D; Zhou L; Guan Y; Chen X; Zhou W; Chen X; Lei P
Bioorg Med Chem Lett; 2010 Sep; 20(18):5439-42. PubMed ID: 20719510
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of OSW-1 analogs with modified side chains and their antitumor activities.
Deng L; Wu H; Yu B; Jiang M; Wu J
Bioorg Med Chem Lett; 2004 Jun; 14(11):2781-5. PubMed ID: 15125932
[TBL] [Abstract][Full Text] [Related]
14. Elucidation of OSW-1-Induced Stress Responses in Neuro2a Cells.
Oh-Hashi K; Nakamura H; Ogawa H; Hirata Y; Sakurai K
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982858
[TBL] [Abstract][Full Text] [Related]
15. MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer.
Greer YE; Gilbert SF; Gril B; Narwal R; Peacock Brooks DL; Tice DA; Steeg PS; Lipkowitz S
Breast Cancer Res; 2019 Feb; 21(1):27. PubMed ID: 30777098
[TBL] [Abstract][Full Text] [Related]
16. Emodin inhibits epithelial‑mesenchymal transition and metastasis of triple negative breast cancer via antagonism of CC‑chemokine ligand 5 secreted from adipocytes.
Song X; Zhou X; Qin Y; Yang J; Wang Y; Sun Z; Yu K; Zhang S; Liu S
Int J Mol Med; 2018 Jul; 42(1):579-588. PubMed ID: 29693154
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer.
Lee J; Lim B; Pearson T; Choi K; Fuson JA; Bartholomeusz C; Paradiso LJ; Myers T; Tripathy D; Ueno NT
Breast Cancer Res Treat; 2019 Jun; 175(2):339-351. PubMed ID: 30826934
[TBL] [Abstract][Full Text] [Related]
18. Effective killing of leukemia cells by the natural product OSW-1 through disruption of cellular calcium homeostasis.
Garcia-Prieto C; Riaz Ahmed KB; Chen Z; Zhou Y; Hammoudi N; Kang Y; Lou C; Mei Y; Jin Z; Huang P
J Biol Chem; 2013 Feb; 288(5):3240-50. PubMed ID: 23250754
[TBL] [Abstract][Full Text] [Related]
19. Structure, bioactivity, and chemical synthesis of OSW-1 and other steroidal glycosides in the genus Ornithogalum.
Tang Y; Li N; Duan JA; Tao W
Chem Rev; 2013 Jul; 113(7):5480-514. PubMed ID: 23530990
[No Abstract] [Full Text] [Related]
20. Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer.
Camorani S; Hill BS; Collina F; Gargiulo S; Napolitano M; Cantile M; Di Bonito M; Botti G; Fedele M; Zannetti A; Cerchia L
Theranostics; 2018; 8(18):5178-5199. PubMed ID: 30429893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
